Research on Leishmania and Leishmaniasis
Deadline for manuscript submissions: 15 April 2024 | Viewed by 6119
Interests: immunopathology of leishmaniasis; infectious disease; immunopathology; immunity; diagnosis; treatment; leishmaniasis
Interests: neglected tropical diseases; parasite; bacteria; virus; fungus; oral and local treatment; formulations; dermatological cream; liposome; nanoparticles; immunity
Special Issues, Collections and Topics in MDPI journals
Leishmania are flagellated kinetoplastid parasites that infect phagocytic cells of the vertebrate host and the alimentary tract of sandfly vectors. Parasites that belong to the genus Leishmania cause a variety of devasting and ofen fatal diseases in humans and domestic animals worldwide depending on the parasite species and the host’s genetic and immunological background. The genus Leishmania comprises a wide range of species, and these different species have different tissue tropisms that are pathogenic to humans, resulting in different clinical forms of human leishmaniasis such as: visceral, cutaneous, anergic diffuse cutaneous, mucocutaneous, or atypical cutaneous disease. The need for new therapeutic strategies is urgent because no vaccine is available, and treatment options are limited due to a lack of specificity, colateral effcts, and the emergence of drug resistance.
In this Special Issue of Microoganisms, we invite you to send your contributions concerning any aspects related to Leishmania and leishmaniasis. We sincerely hope this knowledge can improve the conditions of treatment, follow-up, and cure control of patients, minimize the potential damages this protozoosis can cause to infected individuals, and help establish the public polices for the control of this negleted tropical disease.
Dr. Mãrcia Dalastra Laurenti
Dr. Luiz Felipe Domingues Passero
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- drug treatment
- host-parasite interaction